Bones don’t just grow longer. They build their own plumbing as they go. A new study out of China has tracked down the specific cells responsible for this hidden coordination act, and the answer involves cartilage doing a lot more than anyone suspected.
The work centers on hypertrophic chondrocytes, a type of late-stage cartilage cell that’s been known to contribute to bone formation. What researchers at the Fourth Military Medical University discovered is that these cells don’t just turn into bone. They spawn an entire crew of specialized descendants whose sole job is summoning blood vessels to the construction site.
More than sixty percent of bone-building osteoblasts arise from hypertrophic chondrocytes during normal growth. But exactly how these cartilage cells coordinated bone formation with vascularization has remained murky. The team, led by Professor Liu Yang and Dr. Chao Zheng, used genetic engineering and single-cell analysis to map the process in mice, and what they found challenges the standard narrative.
What Happens When the Architects Go Missing
To probe what hypertrophic chondrocytes actually do, the researchers engineered mice in which these cells and their descendants were selectively eliminated. The effects were severe and immediate. The modified mice were noticeably smaller than their normal counterparts, with shortened limbs, rounded skulls, and malformed spines.
Microscopy revealed that long bones like the femur had significantly fewer blood vessels, especially in regions where bone growth is normally most active. When the team drilled small holes into femurs to mimic injury, healing was delayed and new bone formation was impaired. The skeletal system, essentially, couldn’t function properly without these cells.
“[HC-ablated] mice displayed a dwarfism phenotype, impaired trabecular bone structure, and prolonged healing of drill-hole injuries, underscoring an essential role of HC lineage extension in bone development and repair” – Liu Yang, Professor of Orthopaedics
Importantly, the defects weren’t limited to bone structure. The absence of these cartilage-derived cells also disrupted the formation of blood vessels that normally thread through developing and healing bone tissue. This suggested the cells were doing double duty: building bone while simultaneously calling in its blood supply.
A Dedicated Squad for Blood Vessel Growth
To understand why vascularization faltered, the researchers turned to single-cell RNA sequencing, cataloging the gene expression profiles of thousands of cells derived from hypertrophic chondrocytes. The analysis revealed multiple developmental paths. Some descendants became osteoblasts, others contributed to cartilage or skeletal stem cell pools.
But one small subgroup stood out. These cells, which the team termed Pro-Angiogenic Descendants, or PADs, showed high expression of genes linked to blood vessel formation. They were the only HC descendants dedicated entirely to regulating angiogenesis inside bone.
The PADs secreted a suite of signaling molecules, and among them, thrombospondin 4, or THBS4, emerged as the key driver. Protein analysis and cell-to-cell communication modeling indicated that THBS4 released by PADs directly signaled nearby endothelial cells, essentially telling blood vessel lining to start building.
When hypertrophic chondrocytes were removed, THBS4 levels in bone dropped sharply. Blood vessels in the metaphysis and cortex failed to develop normally, and angiogenesis at injury sites was severely reduced. But here’s where it gets interesting: when the team added THBS4 back into bone explants from the modified mice, blood vessel growth was restored and healing improved. The protein alone was enough to rescue the defect.
The findings show that hypertrophic chondrocytes don’t merely transition into bone-forming cells. Through specialized descendants, they actively coordinate the vascular network that supports bone growth and repair. Frankly, it’s a more sophisticated system than most researchers expected. The work also hints at translational possibilities, suggesting that targeting THBS4 signaling could one day help treat bone injuries or conditions marked by poor skeletal vascularization.
Bone Research: 10.1038/s41413-025-00469-2
ScienceBlog.com has no paywalls, no sponsored content, and no agenda beyond getting the science right. Every story here is written to inform, not to impress an advertiser or push a point of view.
Good science journalism takes time — reading the papers, checking the claims, finding researchers who can put findings in context. We do that work because we think it matters.
If you find this site useful, consider supporting it with a donation. Even a few dollars a month helps keep the coverage independent and free for everyone.